MFDS
- Marketing authorisation holder: JANSSEN BIOTECH
- Status: likely_approved
🇰🇷 Imaavy in South Korea
Imaavy (NIPOCALIMAB) regulatory status in South Korea.
Marketing authorisation
Imaavy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Imaavy approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Imaavy in South Korea?
JANSSEN BIOTECH holds the South Korean marketing authorisation.